These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24535887)

  • 1. Communication and computing technology in biocontainment laboratories using the NEIDL as a model.
    McCall J; Hardcastle K
    Pathog Dis; 2014 Jul; 71(2):96-101. PubMed ID: 24535887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines for Biosafety Training Programs for Workers Assigned to BSL-3 Research Laboratories.
    Homer LC; Alderman TS; Blair HA; Brocard AS; Broussard EE; Ellis RP; Frerotte J; Low EW; McCarthy TR; McCormick JM; Newton JM; Rogers FC; Schlimgen R; Stabenow JM; Stedman D; Warfield C; Ntiforo CA; Whetstone CT; Zimmerman D; Barkley E
    Biosecur Bioterror; 2013 Mar; 11(1):10-9. PubMed ID: 23477631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biocontainment laboratory risk assessment: perspectives and considerations.
    Patterson A; Fennington K; Bayha R; Wax D; Hirschberg R; Boyd N; Kurilla M
    Pathog Dis; 2014 Jul; 71(2):102-8. PubMed ID: 24591404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of a National Biocontainment Laboratory in Emergencies.
    Le Duc JW; Ksiazek TG
    Health Secur; 2015; 13(5):345-8. PubMed ID: 26348927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging infections, biosecurity and public health.
    Byrne G; Cole KS
    Pathog Dis; 2014 Jul; 71(2):93. PubMed ID: 25044874
    [No Abstract]   [Full Text] [Related]  

  • 6. Biosafety and biosecurity measures: management of biosafety level 3 facilities.
    Zaki AN
    Int J Antimicrob Agents; 2010 Nov; 36 Suppl 1():S70-4. PubMed ID: 20801002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of novel mechanisms for housing, handling, and remote monitoring of common marmosets at animal biosafety level 3.
    Powell DS; Walker RC; Heflin DT; Fisher D; Kosky JB; Homer LC; Reed DS; Stefano-Cole K; Trichel AM; Hartman AL
    Pathog Dis; 2014 Jul; 71(2):219-26. PubMed ID: 24453160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of the role and effectiveness of institutional biosafety committees in providing oversight and security at biocontainment laboratories.
    Race MS; Hammond E
    Biosecur Bioterror; 2008 Mar; 6(1):19-35. PubMed ID: 18386970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The changing world of biocontainment and biosecurity.
    Jeggo M
    Dev Biol (Basel); 2007; 128():47-51. PubMed ID: 18084927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Report of the International Conference on Risk Communication Strategies for BSL-4 laboratories, Tokyo, October 3-5, 2007.
    Dickmann P; Keith K; Comer C; Abraham G; Gopal R; Marui E
    Biosecur Bioterror; 2009 Jun; 7(2):227-33. PubMed ID: 19635008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of regulations, safety considerations and physical limitations on research progress at maximum biocontainment.
    Shurtleff AC; Garza N; Lackemeyer M; Carrion R; Griffiths A; Patterson J; Edwin SS; Bavari S
    Viruses; 2012 Dec; 4(12):3932-51. PubMed ID: 23342380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Framework for leadership and training of Biosafety Level 4 laboratory workers.
    Le Duc JW; Anderson K; Bloom ME; Estep JE; Feldmann H; Geisbert JB; Geisbert TW; Hensley L; Holbrook M; Jahrling PB; Ksiazek TG; Korch G; Patterson J; Skvorak JP; Weingartl H
    Emerg Infect Dis; 2008 Nov; 14(11):1685-8. PubMed ID: 18976549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of the CSIRO Australian Animal Health Laboratory.
    Lowenthal J
    J Infect Public Health; 2016; 9(3):236-9. PubMed ID: 27118215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of Biosafety Level-3 (BSL-3) laboratory: important criteria to consider while designing, constructing, commissioning & operating the facility in Indian setting.
    Mourya DT; Yadav PD; Majumdar TD; Chauhan DS; Katoch VM
    Indian J Med Res; 2014 Aug; 140(2):171-83. PubMed ID: 25297350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on Biosafety and Emerging Infections for the Clinical Microbiology Laboratory.
    Pentella MA
    Clin Lab Med; 2020 Dec; 40(4):473-482. PubMed ID: 33121616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adapting high-throughput screening methods and assays for biocontainment laboratories.
    Rasmussen L; Tigabu B; White EL; Bostwick R; Tower N; Bukreyev A; Rockx B; LeDuc JW; Noah JW
    Assay Drug Dev Technol; 2015; 13(1):44-54. PubMed ID: 25710545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between biocontainment laboratories and their communities: a successful work in progress.
    Kanabrocki J
    Trends Microbiol; 2011 May; 19(5):209-10. PubMed ID: 21353566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The global proliferation of high-containment biological laboratories: understanding the phenomenon and its implications.
    Peters A
    Rev Sci Tech; 2018 Dec; 37(3):857-883. PubMed ID: 30964462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in Implementing a Biorisk Management Program at Universitas Indonesia: A Checklist Tool for Biorisk Management.
    Naroeni A; Bachtiar EW; Ibrahim F; Bela B; Kusminanti Y; Pujiriani I; Lestari F
    Health Secur; 2016; 14(6):375-381. PubMed ID: 27830940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of a personnel reliability program as a facilitator of biosafety and biosecurity culture in BSL-3 and BSL-4 laboratories.
    Higgins JJ; Weaver P; Fitch JP; Johnson B; Pearl RM
    Biosecur Bioterror; 2013 Jun; 11(2):130-7. PubMed ID: 23745523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.